MANERIX

This brand name is authorized in Canada, Spain, Ireland, Malta, United Kingdom

Active ingredients

The drug MANERIX contains one active pharmaceutical ingredient (API):

1 Moclobemide
UNII PJ0Y7AZB63 - MOCLOBEMIDE

Moclobemide is an antidepressant which affects the monoaminergic cerebral neurotransmitter system by means of a reversible inhibition of monoamine oxidase preferentially of type A (RIMA).

Read about Moclobemide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MANERIX Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06AG02 Moclobemide N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AG Monoamine oxidase A inhibitors
Discover more medicines within N06AG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 00899356, 02166747
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 59169, 60824
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 26338, 26358, 373837, 373958
Country: IE Health Products Regulatory Authority Identifier(s): 34312, 63384
Country: MT Medicines Authority Identifier(s): AA565/74401

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.